BIOTECH TARGET N V

Insider Reports History

Reporting-owner location: Willemstad, Netherlands Antilles
Latest reporting-owner signature: By: /s/Ivo Betschart
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for BIOTECH TARGET N V

Form 4 holding 10%+ Owner

MACROGENICS INC

Security class: Common Stock
Shares / value: 9,929,963
Estimated value: $119,159,556
Report date: 02 Oct 2023
Price: $12.00
Ownership: Direct

Form 4 holding 10%+ Owner

Esperion Therapeutics, Inc.

Security class: Common Stock
Shares / value: 4,477,964
Estimated value: $5,575,065
Report date: 24 May 2021
Price: $1.24
Ownership: Direct

Form 4 holding 10%+ Owner

Molecular Templates, Inc.

Security class: Prefunded Warrants (right to buy)
Shares / value: 134,667
Estimated value: $316,333
Report date: 02 Apr 2024
Price: $2.35
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

Molecular Templates, Inc.

Security class: Common Warrants (right to buy)
Shares / value: 769,334
Estimated value: $96,167
Report date: 02 Apr 2024
Price: $0.1250
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

Molecular Templates, Inc.

Security class: Common Stock
Shares / value: 0
Estimated value: $0
Report date: 14 Nov 2024
Price: $0.6609
Ownership: Direct

Form 4 holding 10%+ Owner

Radius Health, Inc.

Security class: Common Stock
Shares / value: 0
Estimated value
Report date: 11 Aug 2022
Price: $10.00
Ownership: Direct

Insider Reports Filed by BIOTECH TARGET N V

4

Molecular Templates, Inc.

Report period: 14 Nov 2024
Transactions: 3
Transaction value: -$433,334
Accepted by SEC: 18 Nov 2024, 21:12
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 02 Apr 2024
Transactions: 3
Transaction value: +$1,000,000
Accepted by SEC: 04 Apr 2024, 20:13
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 02 Oct 2023
Transactions: 1
Transaction value: +$669,585
Accepted by SEC: 04 Oct 2023, 15:31
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 07 Sep 2023
Transactions: 1
Transaction value: +$1,052,840
Accepted by SEC: 11 Sep 2023, 15:39
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 17 Jul 2023
Transactions: 1
Transaction value: +$2,000,000
Accepted by SEC: 19 Jul 2023, 15:14
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 14 Feb 2023
Transactions: 1
Transaction value: +$2,532,600
Accepted by SEC: 16 Feb 2023, 11:37
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 19 Jan 2023
Transactions: 1
Transaction value: +$794,925
Accepted by SEC: 23 Jan 2023, 15:21
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 23 Dec 2022
Transactions: 2
Transaction value: +$2,298,600
Accepted by SEC: 28 Dec 2022, 10:03
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 22 Nov 2022
Transactions: 1
Transaction value: +$1,788,180
Accepted by SEC: 25 Nov 2022, 10:37
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 21 Oct 2022
Transactions: 2
Transaction value: +$2,247,600
Accepted by SEC: 25 Oct 2022, 16:19
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 19 Oct 2022
Transactions: 2
Transaction value: +$1,767,484
Accepted by SEC: 21 Oct 2022, 15:03
Role: 10%+ Owner
Next action: Open filing details

4

Radius Health, Inc.

Report period: 15 Aug 2022
Transactions: 1
Transaction value: -$87,335,380
Accepted by SEC: 30 Aug 2022, 12:05
Role: 10%+ Owner
Next action: Open filing details

4

Radius Health, Inc.

Report period: 18 May 2022
Transactions: 1
Transaction value: +$2,661,002
Accepted by SEC: 20 May 2022, 11:35
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 16 May 2022
Transactions: 1
Transaction value: +$236,200
Accepted by SEC: 18 May 2022, 12:21
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 06 Jan 2022
Transactions: 1
Transaction value: +$807,180
Accepted by SEC: 10 Jan 2022, 10:49
Role: 10%+ Owner
Next action: Open filing details

4

Radius Health, Inc.

Report period: 05 Jan 2022
Transactions: 2
Transaction value: +$3,469,060
Accepted by SEC: 07 Jan 2022, 10:33
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 19 Nov 2021
Transactions: 1
Transaction value: +$3,700,320
Accepted by SEC: 23 Nov 2021, 11:29
Role: 10%+ Owner
Next action: Open filing details

4

Radius Health, Inc.

Report period: 29 Sep 2021
Transactions: 1
Transaction value: +$1,294,500
Accepted by SEC: 01 Oct 2021, 10:34
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 28 Sep 2021
Transactions: 2
Transaction value: +$4,111,420
Accepted by SEC: 30 Sep 2021, 15:09
Role: 10%+ Owner
Next action: Open filing details

4

Radius Health, Inc.

Report period: 22 Sep 2021
Transactions: 1
Transaction value: +$1,841,280
Accepted by SEC: 24 Sep 2021, 11:58
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 21 Sep 2021
Transactions: 1
Transaction value: +$4,500,000
Accepted by SEC: 23 Sep 2021, 11:50
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 16 Sep 2021
Transactions: 2
Transaction value: +$12,363,480
Accepted by SEC: 20 Sep 2021, 12:21
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 16 Sep 2021
Transactions: 1
Transaction value: +$613,000
Accepted by SEC: 20 Sep 2021, 12:17
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 26 Jul 2021
Transactions: 2
Transaction value: +$1,091,656
Accepted by SEC: 28 Jul 2021, 12:23
Role: 10%+ Owner
Next action: Open filing details

4

Molecular Templates, Inc.

Report period: 19 Jul 2021
Transactions: 2
Transaction value: +$1,722,502
Accepted by SEC: 21 Jul 2021, 14:02
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 21 Jun 2021
Transactions: 1
Transaction value: +$1,630,170
Accepted by SEC: 23 Jun 2021, 13:33
Role: 10%+ Owner
Next action: Open filing details

4 MGNX

MACROGENICS INC

Report period: 15 Jun 2021
Transactions: 2
Transaction value: +$3,644,005
Accepted by SEC: 17 Jun 2021, 14:54
Role: 10%+ Owner
Next action: Open filing details

3 MGNX

MACROGENICS INC

Report period: 09 Jun 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 11 Jun 2021, 17:21
Role: 10%+ Owner
Next action: Open filing details

4 ESPR

Esperion Therapeutics, Inc.

Report period: 24 May 2021
Transactions: 1
Transaction value: +$2,021,620
Accepted by SEC: 26 May 2021, 11:53
Role: 10%+ Owner
Next action: Open filing details

4 ESPR

Esperion Therapeutics, Inc.

Report period: 19 May 2021
Transactions: 1
Transaction value: +$4,073,960
Accepted by SEC: 21 May 2021, 14:06
Role: 10%+ Owner
Next action: Open filing details

4 ESPR

Esperion Therapeutics, Inc.

Report period: 05 May 2021
Transactions: 2
Transaction value: +$4,648,482
Accepted by SEC: 07 May 2021, 15:23
Role: 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .